Intracellular trafficking of nuclear localization signal conjugated nanoparticles for cancer therapy
Authors:
- Sanjeeb K. SahooSSSanjeeb K. Sahoo
- 1 January 2010
- journal article
- Published by Elsevier in European Journal of Pharmaceutical Sciences
- Vol. 39 (1-3) , 152-163
Abstract
No abstract availableKeywords
This publication has 44 references indexed in Scilit:
- Targeted epidermal growth factor receptor nanoparticle bioconjugates for breast cancer therapyBiomaterials, 2009
- Apoptosis, autophagy, accelerated senescence and reactive oxygen in the response of human breast tumor cells to AdriamycinBiochemical Pharmacology, 2009
- Ligand-based targeted therapy for cancer tissueExpert Opinion on Drug Delivery, 2009
- Design of Biodegradable Nanoparticles for Oral Delivery of Doxorubicin: In vivo Pharmacokinetics and Toxicity Studies in RatsPharmaceutical Research, 2008
- Stabilizer-free poly(lactide-co-glycolide) nanoparticles for multimodal biomedical probesBiomaterials, 2008
- Iron Oxide Nanoparticles for Sustained Delivery of Anticancer AgentsMolecular Pharmaceutics, 2005
- The use of cell-penetrating peptides as a tool for gene regulationDrug Discovery Today, 2004
- Translocation of Branched-Chain Arginine Peptides through Cell Membranes: Flexibility in the Spatial Disposition of Positive Charges in Membrane-Permeable PeptidesBiochemistry, 2002
- Intercalators as Anticancer DrugsCurrent Pharmaceutical Design, 2001
- Intracellular control of gene trafficking using liposomes as drug carriersEuropean Journal of Pharmaceutical Sciences, 2001